NCT02023346
Completed
Not Applicable
Prognostic Awareness and Patient-Physician Communication in Malignant Glioma
Memorial Sloan Kettering Cancer Center1 site in 1 country95 target enrollmentStarted: December 2013Last updated:
ConditionsMalignant Glioma
Overview
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 95
- Locations
- 1
- Primary Endpoint
- measure prognostic awareness
Overview
Brief Summary
The purpose of this study is to learn more about the understanding patients with brain tumors have of their disease and their communication with their physician. Ultimately, we hope to use these findings to improve communication between patients and their doctors.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Patient Inclusion Criteria
- •Age greater than or equal to 18
- •Diagnosis of any WHO grade III or IV glioma
- •Admitted to the inpatient Neurology service
- •Has had at least one outpatient visit with a neuro-oncologist at MSKCC Fluent in English
- •Caregiver Inclusion Criteria
- •Age greater than or equal to 18
- •Identified by the patient as a relative, friend, or partner with whom he or she has a significant relationship and who provides him or her physical or emotional assistance.
- •The patient has himself or herself agreed to participate in this study
Exclusion Criteria
- •Patient Exclusion Criteria
- •A patient will be excluded if the Glasgow Coma Scale is less than
- •The patient must be oriented to self, age, place, and year, and month.
- •Aphasia precluding comprehension and verbalization of consent to participate
- •Patients who cannot verbally demonstrate their understanding of the risks, benefits, and alternatives to participating in the study. This evaluation will take place for otherwise eligible and willing participants, and it will be performed by the NP or MD clinician who is obtaining informed consent and will be documented in the medical record.
- •Caregiver Exclusion Criteria
- •No eligible caregivers who can complete the brief assessment in person or via telephone will be excluded
Outcomes
Primary Outcomes
measure prognostic awareness
Time Frame: 2 years
Prognostic awareness (PA) will be measured using the Chochinov Prognostic Awareness Scale. This scale classifies patients into three categories of awareness: full, limited, or no awareness.
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Prognostic Understanding in ESC (ProgESC Study)Advanced CancerNCT06067087University College, London91
Completed
Not Applicable
Patients' Knowledge and Understanding of Cancer Clinical Trials - a Study of Audio Recorded InformationCancerNCT01502254Karolinska University Hospital130
Completed
Not Applicable
Study of the Health Information Needs of Brain Cancer PatientsBrain TumorNCT01130220University of Florida27
Active, not recruiting
Not Applicable
Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and CaregiversBrain CancerGlioblastomaNCT02375841Memorial Sloan Kettering Cancer Center309
Completed
Not Applicable
Do Patients Participating In Oncology Clinical Trials Understand the Informed Consent Form?CancerOncology ProblemNCT01772511Andrew Sch umacher50